[go: up one dir, main page]

MX9801205A - Compuestos de sales de aminoacidos y procesos para la produccion de los mismos. - Google Patents

Compuestos de sales de aminoacidos y procesos para la produccion de los mismos.

Info

Publication number
MX9801205A
MX9801205A MX9801205A MX9801205A MX9801205A MX 9801205 A MX9801205 A MX 9801205A MX 9801205 A MX9801205 A MX 9801205A MX 9801205 A MX9801205 A MX 9801205A MX 9801205 A MX9801205 A MX 9801205A
Authority
MX
Mexico
Prior art keywords
acid salt
production
salt compounds
amine acid
acid
Prior art date
Application number
MX9801205A
Other languages
English (en)
Other versions
MXPA98001205A (es
Inventor
Seo Hong Yoo
Original Assignee
Seo Hong Yoo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seo Hong Yoo filed Critical Seo Hong Yoo
Publication of MXPA98001205A publication Critical patent/MXPA98001205A/es
Publication of MX9801205A publication Critical patent/MX9801205A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se revela una reaccion estequiométrica de transferencia del radical ácido para la preparacion de una sal ácida de un compuesto amino. La reaccion de transferencia del radical ácido provee sales de aminoácidos de alta pureza y que tiene estructura cristalina de tamaño y forma uniforme.
MX9801205A 1995-08-16 1996-08-16 Compuestos de sales de aminoacidos y procesos para la produccion de los mismos. MX9801205A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08515790 1995-08-16
US08/515,790 US5686588A (en) 1995-08-16 1995-08-16 Amine acid salt compounds and process for the production thereof
PCT/US1996/013246 WO1997007112A1 (en) 1995-08-16 1996-08-16 Amine acid salt compounds and process for the production thereof

Publications (2)

Publication Number Publication Date
MXPA98001205A MXPA98001205A (es) 1998-04-01
MX9801205A true MX9801205A (es) 1998-04-30

Family

ID=24052741

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9801205A MX9801205A (es) 1995-08-16 1996-08-16 Compuestos de sales de aminoacidos y procesos para la produccion de los mismos.

Country Status (13)

Country Link
US (1) US5686588A (es)
EP (1) EP0859768B1 (es)
JP (1) JPH11508601A (es)
KR (1) KR100259205B1 (es)
CN (1) CN100338050C (es)
AT (1) ATE230737T1 (es)
AU (1) AU713507B2 (es)
BR (1) BR9610288A (es)
CA (1) CA2227264C (es)
DE (1) DE69625699T2 (es)
IL (1) IL123212A0 (es)
MX (1) MX9801205A (es)
WO (1) WO1997007112A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
AU758679B2 (en) 1998-07-24 2003-03-27 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
EP1255566A2 (en) * 2000-02-04 2002-11-13 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
CN101035541B (zh) * 2004-08-30 2012-05-30 柳署弘 溶解的udca在局灶缺血模型中的神经保护作用
AU2005295541B2 (en) * 2004-10-15 2011-02-17 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE602005025391D1 (de) * 2004-11-01 2011-01-27 Seo Hong Yoo Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107424A (en) * 1972-10-06 1978-08-15 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CH654830A5 (en) * 1980-01-08 1986-03-14 Glaxo Group Ltd Aziridine derivative
CA1171096A (en) * 1980-01-08 1984-07-17 Glaxo Group Limited Process for the preparation of a furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
PT74459B (en) * 1981-02-20 1984-10-09 Glaxo Group Ltd Process for the preparation of a furan derivative
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
GB8415254D0 (en) * 1984-06-15 1984-07-18 Glaxo Group Ltd Amine derivatives
HU9203905D0 (en) * 1989-04-05 1993-04-28 Glaxo Group Ltd Method for producing ranitidine
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
KR19990037637A (ko) 1999-05-25
AU713507B2 (en) 1999-12-02
BR9610288A (pt) 1999-07-27
CN100338050C (zh) 2007-09-19
IL123212A0 (en) 1998-09-24
WO1997007112A1 (en) 1997-02-27
AU6725596A (en) 1997-03-12
JPH11508601A (ja) 1999-07-27
EP0859768A4 (en) 1998-11-11
EP0859768A1 (en) 1998-08-26
CN1198744A (zh) 1998-11-11
EP0859768B1 (en) 2003-01-08
DE69625699D1 (de) 2003-02-13
CA2227264A1 (en) 1997-02-27
KR100259205B1 (ko) 2000-07-01
CA2227264C (en) 2002-10-22
US5686588A (en) 1997-11-11
ATE230737T1 (de) 2003-01-15
DE69625699T2 (de) 2003-11-06

Similar Documents

Publication Publication Date Title
MX9801205A (es) Compuestos de sales de aminoacidos y procesos para la produccion de los mismos.
ES8801920A1 (es) Procedimiento para la obtencio de enaminas
CA2238427A1 (en) Production method of aminobenzene compound
CA2216633A1 (en) Synthesis of bis-indolylmaleimides
HU9301931D0 (en) Process for the production of azabicyclo [2.2.2] octane-3-imines and thereof inrtermediers
DE3568580D1 (en) Process for preparing alkanephosphonous acids
ES9100017A1 (es) Un procedimiento para la preparacion de 2-amino-6-cloropurina.
HUT45518A (en) Process for producing 1,5-benzothiazepine derivatives and pharmaceutics comprising these compounds
ES8304971A1 (es) Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos.
NZ513551A (en) Novel process for preparing alendronic acid
CA2046293A1 (en) Preparation of substituted ethenes
CA2145181A1 (en) Process for preparing 1-2,-substituted-5-formylimidazoles
EP0341694A3 (en) Method for production of 3-exomethylenecepham derivatives
HUT46701A (en) Process for producing alpha-amino-alkyl-phosphonic acids
HUT67743A (en) Process for producing crystalline beta-lactame-monohydrate
MY105374A (en) A process for the preparation of 7-amino-3-methoxymeth- yl-ceph-3-em-4-carboxylic acid.
ES2020145A6 (es) Procedimiento de obtencion de esteres del acido 2-(2,6-diclorofenil)amino) fenilacetoxiacetico.
GR3004109T3 (es)
TW370520B (en) A process for the preparation of NG-monomethyl-L-arginine hydrochloride
ES8506303A1 (es) Un procedimiento para preparar derivados de pirimidin-4-ona
DE3269684D1 (en) Process for preparing (thio)hydantoins
EP0844236A4 (en) METHOD FOR PRODUCING CARBAMOYL METHYL URINE DERIVATIVES
ES8603819A1 (es) Procedimiento para la fabricacion de derivados de pirrolidi-na
SG43092A1 (en) Process for preparing 5-arylhydantoin
ES2115535A1 (es) Procedimiento para la preparacion de amidas de d-(-)-aminoacidos.